The Cisatracurium Besylate Injection, cataloged under National Stock Number 6505-01-434-0939, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Abbvie Us Llc. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-434-0939 |
| Primary Part Number | NDC00074-4378--05 |
| Item Name | Cisatracurium Besylate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Abbvie Us Llc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00074-4378--05 PRIMARY | Abbvie Us Llc (USA) |
| NDC63323-0416-05 PRIMARY | Fresenius Kabi, Llc (USA) |
| NDC71288-0712-06 PRIMARY | Meitheal Pharmaceuticals, Inc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM217091 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1594648 | 5/1 Secondary reference U.S. Government activity |
| NDC00409-1098-02 | 3/2 Design control — primary reference U.S. Government activity |
NSN 6505-01-434-0939 is a Cisatracurium Besylate Injection, manufactured by Abbvie Us Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-434-0939 has 3 manufacturer part numbers on file: NDC00074-4378--05 (Abbvie Us Llc), NDC63323-0416-05 (Fresenius Kabi, Llc), NDC71288-0712-06 (Meitheal Pharmaceuticals, Inc).
Key specifications for NDC00074-4378--05: Special Features: 2MG/ML; 5ML, SINGLE DOSE VIAL 10'S. REFRIGERATE AT 2-8 DEG. C IN TRAY; DO NOT FREEZE. PROTECT FROM LIGHT. UPON REMOVAL FROM REFRIGERATION TO ROOM TEMPERATURE, USE WITHIN 21 DAYS EVEN IF RE-REFRIGERATED.; Part Name Assigned by Controlling Agency: CISATRACURIUM BESYLATE INJECTION 2MG/ML 5ML VIAL 10S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.